Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125618021 | 12561802 | 1 | I | 1998 | 20160610 | 20160715 | 20160715 | EXP | US-FRI-1000085732 | FOREST | 70.81 | YR | F | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125618021 | 12561802 | 1 | PS | LINZESS | LINACLOTIDE | 1 | Unknown | UNK | U | 202811 | CAPSULE | ||||||||
125618021 | 12561802 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG, ONE PUFF TWICE DAILY | 1146241 | 0 | |||||||||
125618021 | 12561802 | 3 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG, ONE PUFF TWICE DAILY | 1146241 | 0 | |||||||||
125618021 | 12561802 | 4 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG, ONE PUFF TWICE DAILY | 1146241 | 0 | |||||||||
125618021 | 12561802 | 5 | SS | BUDESONIDE. | BUDESONIDE | 1 | Respiratory (inhalation) | TWO TIMES A DAY | 0 | INHALER | |||||||||
125618021 | 12561802 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 80 MG | 0 | 40 | MG | BID | |||||||
125618021 | 12561802 | 7 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | 25 MG | U | U | 0 | 25 | MG | TABLET | QD | ||||
125618021 | 12561802 | 8 | SS | ALBUTEROL. | ALBUTEROL | 1 | Unknown | UNK | 0 | ||||||||||
125618021 | 12561802 | 9 | C | PROLIA | DENOSUMAB | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | DAILY | 0 | |||||||||||
125618021 | 12561802 | 11 | C | FENTANYL. | FENTANYL | 1 | 25 MCG | 0 | 25 | UG | |||||||||
125618021 | 12561802 | 12 | C | LOSARTAN. | LOSARTAN | 1 | 100 MG | 0 | 100 | MG | QD | ||||||||
125618021 | 12561802 | 13 | C | TIGAN | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 900 MG | 0 | 300 | MG | TID | ||||||||
125618021 | 12561802 | 14 | C | ODANSETRON | ONDANSETRON | 1 | 120 MG | 0 | 40 | MG | TID | ||||||||
125618021 | 12561802 | 15 | C | KLONOPIN | CLONAZEPAM | 1 | 1.5 MG | 0 | .5 | MG | TID | ||||||||
125618021 | 12561802 | 16 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | .5 | MG | TID | |||||||||
125618021 | 12561802 | 17 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | .5 | MG | TID | |||||||||
125618021 | 12561802 | 18 | C | LUVOX | FLUVOXAMINE MALEATE | 1 | 200 MG | 0 | 100 | MG | BID | ||||||||
125618021 | 12561802 | 19 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | TAKES 50 MCG ONE DAY AND 75 MCG THE NEXT | 0 | |||||||||||
125618021 | 12561802 | 20 | C | ZIOPTAN | TAFLUPROST | 1 | AT NIGHT | 0 | EYE DROPS | ||||||||||
125618021 | 12561802 | 21 | C | REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | 1 | FOUR TIMES A DAY | 0 | |||||||||||
125618021 | 12561802 | 22 | C | REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | 1 | FOUR TIMES A DAY | 0 | |||||||||||
125618021 | 12561802 | 23 | C | COLACE | DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 24 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG | 0 | 81 | MG | QD | ||||||||
125618021 | 12561802 | 25 | C | GLUCERNA | AMINO ACIDSDEXTROSEELECTROLYTES NOSSOYBEAN OILVITAMINS | 1 | THREE TIMES A DAY | 0 | LIQUID | ||||||||||
125618021 | 12561802 | 26 | C | ALIGN | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | 1 | DAILY | 0 | |||||||||||
125618021 | 12561802 | 27 | C | PHAZYME | DIMETHICONE 410 | 1 | 180 MG | 0 | 180 | MG | QD | ||||||||
125618021 | 12561802 | 28 | C | CENTRUM | VITAMINS | 1 | DAILY | 0 | |||||||||||
125618021 | 12561802 | 29 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 2000 | 0 | |||||||||||
125618021 | 12561802 | 30 | C | ZINC | ZINCINC CHLORIDE | 1 | 550 MG | 0 | 550 | MG | QD | ||||||||
125618021 | 12561802 | 31 | C | CALCIUM | CALCIUM | 1 | 500 MG | 0 | 500 | MG | QD | ||||||||
125618021 | 12561802 | 32 | C | FERROUS IRON | 2 | UNK | 0 | ||||||||||||
125618021 | 12561802 | 33 | C | MULTIPLE SKIN CREAMS | 2 | Vaginal | UNK | 0 | CREAM | ||||||||||
125618021 | 12561802 | 34 | C | CHLORTALIDONE | CHLORTHALIDONE | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 35 | C | CHLORTALIDONE | CHLORTHALIDONE | 1 | 0 | ||||||||||||
125618021 | 12561802 | 36 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 37 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 38 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 39 | C | BOTOX | ONABOTULINUMTOXINA | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 40 | C | STEROID | UNSPECIFIED INGREDIENT | 1 | UNK | 0 | |||||||||||
125618021 | 12561802 | 41 | C | RELISTOR | METHYLNALTREXONE BROMIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125618021 | 12561802 | 2 | Obstructive airways disorder |
125618021 | 12561802 | 3 | Emphysema |
125618021 | 12561802 | 4 | Lung disorder |
125618021 | 12561802 | 5 | Emphysema |
125618021 | 12561802 | 6 | Hiatus hernia |
125618021 | 12561802 | 7 | Constipation |
125618021 | 12561802 | 9 | Osteoarthritis |
125618021 | 12561802 | 10 | Blood cholesterol increased |
125618021 | 12561802 | 11 | Pain |
125618021 | 12561802 | 12 | Hypertension |
125618021 | 12561802 | 13 | Nausea |
125618021 | 12561802 | 14 | Vomiting |
125618021 | 12561802 | 15 | Feeling of relaxation |
125618021 | 12561802 | 16 | Pain |
125618021 | 12561802 | 17 | Nervous system disorder |
125618021 | 12561802 | 18 | Neuralgia |
125618021 | 12561802 | 19 | Thyroid disorder |
125618021 | 12561802 | 20 | Glaucoma |
125618021 | 12561802 | 21 | Eye lubrication therapy |
125618021 | 12561802 | 22 | Lacrimation increased |
125618021 | 12561802 | 24 | Ill-defined disorder |
125618021 | 12561802 | 25 | Diabetes mellitus |
125618021 | 12561802 | 26 | Probiotic therapy |
125618021 | 12561802 | 28 | Hypovitaminosis |
125618021 | 12561802 | 29 | Osteoporosis |
125618021 | 12561802 | 30 | Glossitis |
125618021 | 12561802 | 31 | Osteoporosis |
125618021 | 12561802 | 32 | Anaemia |
125618021 | 12561802 | 33 | Vulvovaginal disorder |
125618021 | 12561802 | 34 | Diuretic therapy |
125618021 | 12561802 | 35 | Blood pressure abnormal |
125618021 | 12561802 | 38 | Candida infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125618021 | 12561802 | OT |
125618021 | 12561802 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125618021 | 12561802 | Accident at home | |
125618021 | 12561802 | Adverse event | |
125618021 | 12561802 | Agitation | |
125618021 | 12561802 | Anxiety | |
125618021 | 12561802 | Arthropathy | |
125618021 | 12561802 | Asthenia | |
125618021 | 12561802 | Back pain | |
125618021 | 12561802 | Body height decreased | |
125618021 | 12561802 | Cardiac disorder | |
125618021 | 12561802 | Circumstance or information capable of leading to medication error | |
125618021 | 12561802 | Constipation | |
125618021 | 12561802 | Device difficult to use | |
125618021 | 12561802 | Device issue | |
125618021 | 12561802 | Drug ineffective | |
125618021 | 12561802 | Dry mouth | |
125618021 | 12561802 | Dyspnoea | |
125618021 | 12561802 | Emphysema | |
125618021 | 12561802 | Feeding disorder | |
125618021 | 12561802 | Fungal infection | |
125618021 | 12561802 | Hernia | |
125618021 | 12561802 | Injury associated with device | |
125618021 | 12561802 | Insomnia | |
125618021 | 12561802 | Intentional product misuse | |
125618021 | 12561802 | Lung disorder | |
125618021 | 12561802 | Malaise | |
125618021 | 12561802 | Malnutrition | |
125618021 | 12561802 | Neck pain | |
125618021 | 12561802 | Neuralgia | |
125618021 | 12561802 | Off label use | |
125618021 | 12561802 | Osteoporosis | |
125618021 | 12561802 | Ovarian cancer | |
125618021 | 12561802 | Pain | |
125618021 | 12561802 | Peripheral venous disease | |
125618021 | 12561802 | Product taste abnormal | |
125618021 | 12561802 | Product use issue | |
125618021 | 12561802 | Seizure | |
125618021 | 12561802 | Spinal cord injury cervical | |
125618021 | 12561802 | Spinal fracture | |
125618021 | 12561802 | Syncope | |
125618021 | 12561802 | Throat lesion | |
125618021 | 12561802 | Tongue injury | |
125618021 | 12561802 | Urinary bladder rupture | |
125618021 | 12561802 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125618021 | 12561802 | 2 | 20151020 | 0 | ||
125618021 | 12561802 | 3 | 20151020 | 0 | ||
125618021 | 12561802 | 4 | 20151020 | 0 |